Association between the low molecular weight cytosolic acid phosphatase gene ACP1*A and comorbid features of Tourette syndrome

Neuroscience Letters

Volumn 330, Issue 2, 2002, Pages 198-200

  Bottini, Nunzio ^a   MacMurray, James ^b   Rostamkani, Masoud ^c   McGue, Matt ^d   Iacono, William G ^d   Comings, David E ^c  

^a BURNHAM INSTITUTE   (United States)

^b MGI Applied Genomics   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

ACP1; Attention deficit hyperactivity disorder; Conduct disorder; Gene; Protein tyrosine phosphatase; Tourette syndrome

Indexed keywords

ACID PHOSPHATASE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CAUCASIAN; CHILD; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CYTOSOL; EUROPE; GENE FREQUENCY; GILLES DE LA TOURETTE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; SCREENING; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CYTOSOL; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS; TOURETTE SYNDROME; VARIATION (GENETICS);

EID: 0037144203     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00750-4     Document Type: Article

References (15)

1. Arnsten A.F. Modulation of prefrontal cortical-striatal circuits: relevance to therapeutic treatments for Tourette syndrome and attention-deficit hyperactivity disorder. Adv. Neurol. 85:2001;333-341.
2. Coffey B.J., Biederman J., Geller D.A., Spencer T., Park K.S., Shapiro S.J., Garfield S.B. The course of Tourette's disorder: a literature review. Harv. Rev. Psychiatry. 8:(4):2000;192-198.
3. Comings D.E. Tourette Syndrome and Human Behavior. 1990;Hope Press, Duarte, CA.
4. Comings, D.E., Rostamkhani, M., Iacono, W.G., McGue, W.G., Bottini, N. and MacMurray, J.P., Association Between Depression and the Low Molecular Weight Cytosolic Acid Phosphatase Gene ACP1*A, submitted for publication.
5. Dunah A.W., Standaert D.G. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J. Neurosci. 21:2001;5546-5558.
6. Humblot N., Esteve L., Burgun C., Aunis D., Zwiller J. 5-Hydroxytryptamine induces TIS8/egr-1 and c-fos expression in PC12 cells: involvement of tyrosine protein phosphorylation. Eur. J. Neurosci. 9:(4):1997;84-92.
7. Magherini F., Giannoni E., Raugei G., Cirri P., Paoli P., Modesti A., Camici G., Ramponi G. Cloning of murine low molecular weight phosphotyrosine protein phosphatase cDNA: identification of a new isoform. FEBS Lett. 437:1998;263-266.
8. Nair V.D., Niznik H.B., Mishra R.K. NMDA and dopamine D2 receptor interaction in human neuroblastoma SH-SY5Y cells involves tyrosine kinase and phosphatase. NeuroReport. 7:1996;2937-2940.
9. Paul S., Snyder G.L., Yokakura H., Picciotto M.R., Nairn A.C., Lombroso P.J. The dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase step via a PKA-dependent pathway. J. Neurosci. 20:2000;5630-5638.
10. Prasad P.D., Torres-Zamorano V., Kekuda R., Leibach F.H., Ganapathy V. Functional link between tyrosine phosphorylation and human serotonin transporter gene expression. Eur. J. Pharmacol. 325:(3):1997;85-92.
11. Ramponi G., Stefani M. Structure and function of the low Mr phosphotyrosine protein phosphatases. Biochim. Biophys. Acta. 1341:1997;137-156.
12. Sensabaugh G.F., Lazaruk K.A. A Taq I site identifies the *A allele at the ACP1 locus. Hum. Mol. Genet. 14:1993;1079.
13. Stein E., Lane A.A., Cerretti D.P., Schoecklmann H.O., Scroff A.D., Van Etten R.L., Daniel T.O. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev. 12:1998;667-678.
14. Stephens R.J., Sandor P. Aggressive behavior in children with Tourette syndrome and comorbid attention-deficit hyperactivity disorder and obsessive-compulsive disorder. Can. J. Psychiatry. 44:(10):1999;1036-1042.
15. Tanino H., Yoshida J., Yamamoto R., Kobayashi Y., Shimohama S., Fujimoto S. Abundance of low molecular weight phosphotyrosine protein phosphatase in the nerve-end fraction in the brain. Biol. Pharm. Bull. 22:1999;794-798.